This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Timing matters: choose or avoid depending on goals, fees, and flexibility. This guide offers practical criteria to decide for retirement planning.
21,768 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
A major institutional move grabs attention as landmark investment partners cuts its stake in Howard Hughes Holdings. ...
Privacy-focused crypto Zcash is quietly advancing features that could challenge Bitcoin and Ethereum. This in-depth g...
A big investment firm has exited its complete stake in a biotech company, disclosed in an SEC filing. The move provid...
Inflation surging is reordering the playbook for investors as political pressure over rate cuts intensifies. This art...
A pop-up that looked like Apple Support pulled a woman into withdrawing thousands and shipping cash by Uber. This cau...
As policy moves shift, top high yield savings accounts are offering higher APYs. This explainer shows how these rates...
With inflation cooling but living costs persistent, savvy savers are turning to high-yield savings accounts to protec...
President Trump signals possible limited military action against Iran as nuclear talks proceed, a move that could res...
The Pentagon is releasing new files on unidentified phenomena, inviting the public to draw their own conclusions. The...
Firms are pressuring AI to beat human averages before deployment, a trend that and reshapes products, jobs, and perso...
OpenAI has redefined its mission and governance, moving into a for-profit structure and removing safety language from...